Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
PFIZER Inc has agreed to buy Medivation Inc for about US$14 billion, gaining a blockbuster prostate cancer treatment and leaving French drugmaker Sanofi jilted.
Pfizer will pay US$81.50 a share in cash, the companies said in a statement on Monday. Shares of Medivation,